Immunefi vs Solv Protocol — how do they compare? Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume), while Solv Protocol trades at Rp40 (market cap Rp169,88M, Rp64,45M 24h volume). The key difference: Solv Protocol is far larger — about 6.3× Immunefi's market cap, and Immunefi's circulating supply is 873,4M / 10B IMU (9%) versus 4,3B / 9,7B SOLV (45%) for Solv Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Immunefi for 5 Days and Solv Protocol for 13 Days on average.
| IMU | SOLV | |
|---|---|---|
Market Cap | Rp27,03M | Rp169,88M |
Volume (24h) | Rp39,91M | Rp64,45M |
Circulating Supply | 873,4M / 10B IMU (9%) | 4,3B / 9,7B SOLV (45%) |
Typical Hold Time | 5 Days | 13 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →Solv Protocol is a premier Bitcoin staking platform that utilizes SolvBTC to unlock the full potential of over $1 trillion in Bitcoin assets. With its Staking Abstraction Layer (SAL), Solv provides a seamless, secure, and transparent Bitcoin staking experience, paving the way for the widespread adoption of BTCFi.
Read more on SOLV →